SCHEMBL6174887

SCHEMBL6174887

Cc1ccc(Oc2ccc(Nc3ncnc4ccc(C#CCNC(=O)NCCF)cc34)cc2Cl)cn1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 12/20 0.53
ERBB2 P04626 11/20 0.49
FECH P22830 1/20 0.47
CDK8 P49336 1/20 0.47
MAP2K5 Q13163 1/20 0.47
CDK19 Q9BWU1 1/20 0.47
MKNK2 Q9HBH9 1/20 0.47
HDAC3 O15379 2/20 0.47
HDAC4 P56524 2/20 0.47
HDAC1 Q13547 2/20 0.47
HDAC7 Q8WUI4 2/20 0.47
HDAC2 Q92769 2/20 0.47
HDAC10 Q969S8 2/20 0.47
HDAC11 Q96DB2 2/20 0.47
HDAC8 Q9BY41 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
HDAC9 Q9UKV0 2/20 0.47
HDAC5 Q9UQL6 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173154 0.94 EGFR (0.54) EGFRERBB2FECHCDK8MAP2K5
SCHEMBL6189105 0.94 EGFR (0.52) EGFRERBB2FECHCDK8MAP2K5
SCHEMBL6174823 0.92 EGFR (0.54) EGFRERBB2FECHCDK8MAP2K5
SCHEMBL4798006 0.91 EGFR (0.52) EGFRERBB2FECHCDK8MAP2K5
SCHEMBL6177127 0.91 ERBB2 (0.52) EGFRERBB2FECHCDK8MAP2K5
SCHEMBL6177010 0.91 ERBB2 (0.54) EGFRERBB2FECHCDK8MAP2K5
SCHEMBL4616858 0.90 EGFR (0.53) EGFRERBB2FECHCDK8MAP2K5
SCHEMBL6173292 0.89 EGFR (0.52) EGFRERBB2FECHCDK8MAP2K5
SCHEMBL6172916 0.89 ERBB2 (0.55) EGFRERBB2FECHCDK8MAP2K5
SCHEMBL6174626 0.89 EGFR (0.54) EGFRERBB2FECHCDK8MAP2K5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1292591-B1 SUBSTITUTED BICYCLIC DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH PFIZER PROD INC (US) 2005-02-02 EP disclosed